AYTU BIOPHARMA, INC — Director's Dealing 2016

Sep 2, 2016

SEC Form 3/A — Form 3/A

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-07-12

Reporting Person: Cantrell Gary (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$0.50	2021-05-06	Common Stock (45000)		Direct

Footnotes

F1: These warrants were omitted from the Reporting Person's original Form 3 filed on July 14, 2016, and were also omitted from the Form 4 filed by the Reporting Person after the original Form 3 was filed. This amended Form 3 does not give effect to a 1-for-12 reverse stock split effected on June 30, 2016.